Sight Sciences, Inc. (SGHT) Financial Statements
Sight Sciences, Inc. (SGHT) reported trailing twelve-month revenue of $83.4M (up 9.3% year on year) and net income of -$29.8M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$23.3M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SGHTSight Sciences, Inc.Follow SGHT — free
—
Price chart with a free account
- Market cap
- 495.2M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Revenue | 49.0 | 71.3 | 81.1 | 79.9 | 77.4 | 83.4 | |
| Gross profit | 40.3 | 59.0 | 69.2 | 68.3 | 66.7 | 73.3 | |
| Research & development | 15.6 | 22.9 | 17.6 | 18.0 | 14.6 | 10.8 | |
| Operating income | -51.5 | -84.0 | -57.3 | -50.5 | -37.1 | -27.9 | |
| Pre-tax income | -62.8 | -86.2 | -55.4 | -51.3 | -38.4 | -29.8 | |
| Income tax | 0.2 | 0.0 | 0.1 | 0.2 | 0.0 | -0.0 | |
| Net income | -63.0 | -86.2 | -55.5 | -51.5 | -38.4 | -29.8 | |
| Diluted EPS ($) | -2.36 | -1.80 | -1.14 | -1.03 | -0.74 | -0.56 | |
| Diluted shares (mn) | — | 47.8 | 48.6 | 50.1 | 52.1 | — |
USD millions · SEC XBRL
Sight Sciences, Inc. — questions
- What is Sight Sciences, Inc.'s revenue?
- $83.4M over the twelve months to 2026-06-30, up 9.3% year on year, from its 10-Q and 10-K filings.
- What is Sight Sciences, Inc.'s net income?
- -$29.8M over the twelve months to 2026-06-30.
- What is Sight Sciences, Inc.'s free cash flow?
- -$23.3M over the twelve months to 2026-06-30.
- What are Sight Sciences, Inc.'s diluted earnings per share?
- $-0.56 over the twelve months to 2026-06-30.
Every figure on this page comes from Sight Sciences, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.